Truist Financial Corp Emergent Bio Solutions Inc. Transaction History
Truist Financial Corp
- $62.9 Billion
- Q3 2024
A detailed history of Truist Financial Corp transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Truist Financial Corp holds 144,196 shares of EBS stock, worth $1.33 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
144,196
Previous 131,526
9.63%
Holding current value
$1.33 Million
Previous $897,000
34.23%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding EBS
# of Institutions
160Shares Held
33.8MCall Options Held
453KPut Options Held
931K-
Black Rock Inc. New York, NY3.84MShares$35.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$31.4 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.49MShares$23.1 Million0.03% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA2.22MShares$20.6 Million0.0% of portfolio
-
State Street Corp Boston, MA1.91MShares$17.7 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $461M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...